리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 06월
페이지 정보:영문 190 Pages
라이선스 & 가격 (부가세 별도)
한글목차
협업 케어 모델 세계 시장은 2030년까지 49억 달러에 달할 전망
2024년에 18억 달러로 추정되는 협업 케어 모델 세계 시장은 2024년부터 2030년까지 CAGR 17.6%로 성장하여 2030년에는 49억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 웹 기반 전개는 CAGR 18.6%를 기록하며 분석 기간 종료시에는 30억 달러에 달할 것으로 예측됩니다. 클라우드 기반 전개 부문의 성장률은 분석 기간 동안 CAGR 16.2%로 추정됩니다.
미국 시장은 4억 8,330만 달러, 중국은 CAGR 16.5%로 성장 예측
미국의 협업 케어 모델 시장은 2024년에 4억 8,330만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 16.5%로 2030년까지 7억 4,540만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 16.3%와 15.1%로 예측됩니다. 유럽에서는 독일이 CAGR 약 12.8%로 성장할 것으로 예측됩니다.
세계의 협업 케어 모델 시장 - 주요 동향과 촉진요인 정리
왜 협업 진료 모델이 통합 행동 의료의 중요한 프레임워크로 부상하고 있는가?
협업 케어 모델(CoCM)은 일차 진료 환경 내에서 행동 의료 서비스를 통합하기 위해 고안된 증거 기반 프레임워크로 각광받고 있습니다. 이 모델은 일차 진료 제공자, 행동 건강 임상의, 정신과 컨설턴트를 포함한 팀 기반 접근 방식을 통해 환자 중심의 협력적 치료를 촉진하여 정신과와 신체 건강 관리 사이의 오랜 분절에 대처합니다. CoCM은 일반 진료에 정신건강 서비스를 통합함으로써 접근성을 높이고 편견을 줄이며, 특히 우울증, 불안 장애, 약물 사용 장애와 같은 증상에 대한 조기 개입을 지원합니다.
정신건강이 전반적인 건강 결과의 주요 결정 요인이라는 인식이 높아짐에 따라, 이 모델은 만성질환 관리를 최적화하고 환자 만족도를 높이기 위해 의료 시스템, 보험사, 정책 입안자들이 적극적으로 추진하고 있습니다. CoCM은 임상 결과를 개선할 뿐만 아니라 응급실 방문, 입원, 전문의 의뢰를 줄임으로써 비용 효율성도 향상시킨다는 증거가 있으며, CoCM은 확장 가능하고 적응 가능한 프레임워크이기 때문에 건강 형평성을 개선하고 다양한 인구집단의 미충족 정신건강 요구를 충족시킬 수 있는 전략적 수단입니다. 다양한 인구집단의 충족되지 않은 정신건강의 필요를 충족시키기 위한 전략적 수단으로 점점 더 주목받고 있습니다.
디지털 플랫폼과 임상 프로토콜은 어떻게 협업 케어의 효과를 높이고 있는가?
기술은 협업 케어 모델의 규모와 효과를 높이는 데 있어 핵심적인 역할을 하고 있습니다. 디지털 플랫폼은 케어 코디네이션을 촉진하고, 임상 등록을 관리하며, PHQ-9 및 GAD-7과 같은 표준화된 평가 도구를 통해 환자의 진행 상황을 모니터링하는 데 사용되고 있습니다. 이러한 플랫폼을 통해 행동 치료 관리자는 사례 수를 추적하고, 아웃리치의 우선순위를 정하고, 일차 진료 및 정신과 컨설턴트와 원활하게 소통할 수 있습니다.
이러한 플랫폼에 내장된 임상 프로토콜은 증거에 기반한 치료 경로를 지원하고 환자 반응에 따라 적시에 조정할 수 있도록 하며, CoCM의 필수 요소인 측정 기반 치료는 원격 증상 추적 및 가상 상담을 용이하게 하는 환자 맞춤형 앱과 원격진료 도구에 의해 점점 더 많이 지원되고 있습니다. 원격 증상 추적 및 가상 상담을 용이하게 하는 환자 대상 앱과 원격의료 도구에 의해 점점 더 많이 지원되고 있습니다. 하이브리드 진료 제공 모델에 대한 수요가 증가함에 따라 디지털 인프라의 통합은 협업 케어팀이 진료의 질과 연속성을 해치지 않고 지리적으로 분산되어 있거나 자원에 제약이 있는 집단에 서비스를 제공할 수 있게 해줍니다.
협업 케어 모델 도입을 추진하고 있는 의료 시스템과 환자 집단은?
대규모 의료 시스템, 연방정부 인증 의료센터(FQHC), 책임의료기관(ACO), 통합의료 제공 네트워크(IDN) 등이 협업 케어 모델을 가장 적극적으로 채택하고 있습니다. 이러한 조직들은 이 모델이 가치 기반 진료 목표에 부합하고, 집단 건강, 진료 조정, 환자 만족도와 관련된 성과 지표를 강화할 수 있다는 점에서 이점을 누리고 있습니다. 특히 정신과 의사가 현장에서 직접 대응하지 않고도 정신과 전문의가 구조화된 정신의료를 제공할 수 있어 큰 효과를 발휘합니다.
당뇨병, 심혈관질환, 만성 통증 등 만성질환을 앓고 있는 환자군은 행동 건강 상태와 중복되는 경우가 많기 때문에 CoCM의 주요 수혜자입니다. 이 모델은 또한 농촌 지역, 메디케이드 수급자, 사회경제적으로 취약한 그룹 등 정신건강에 대한 접근에 높은 장벽이 있는 소외된 지역사회에도 적합합니다. 신뢰할 수 있는 의료 환경에 행동치료 서비스를 통합함으로써, 이 모델은 단독으로 정신보건 서비스를 회피하거나 이탈할 수 있는 환자들의 치료 접근성을 개선하고, 치료 지연을 줄이며, 치료 순응도를 높일 수 있습니다.
정책적 지원, 상환 구조, 인력 모델은 확장 가능성에 어떤 영향을 미치고 있는가?
특히 미국에서는 메디케어-메디케이드 서비스 센터(CMS)가 CoCM 서비스 상환을 위한 특정 청구 코드를 승인했습니다. 이러한 코드는 케어 코디네이션과 팀 기반 개입에 대한 인센티브를 제공하고, 일차 의료에 행동 치료를 통합할 수 있는 실행 가능한 재정 모델을 제공합니다. 상업적 지불자들도 협업 케어의 원칙에 부합하는 상환 프레임워크를 마련하기 시작했지만, 지역에 따라서는 보험 적용 범위의 다양성과 청구의 복잡성이 장벽으로 작용하고 있습니다.
효과적인 실행을 위해서는 인력 확보와 훈련이 필수적입니다. 이 모델에서는 전담 행동 치료 매니저(종종 임상 사회복지사, 심리학자, 간호사)가 정신과 전문의의 자문과 일차 의료 리더십에 의해 지원됩니다. 이러한 인력을 확충하기 위해선 다학제적 교육 프로그램, 임상 감독 체계, 기술 도입에 대한 투자가 필요합니다. 협력적 문화를 조성하고 의료팀 간의 재정적 인센티브를 조정할 수 있는 의료 시스템은 다양한 진료 환경에서 이 모델을 유지하고 성공적으로 확장할 수 있는 가능성이 높습니다.
협업 케어 모델 시장의 성장을 촉진하는 요인은 무엇인가?
협업 케어 모델 시장의 성장은 정신건강 위기에 대한 인식의 증가, 통합된 가치 기반 의료로의 전환, 그리고 행동 치료의 임상적 및 경제적 이점이 입증됨에 따라 촉진되고 있습니다. 의료 시스템이 만성질환자 집단 내 정신질환의 동반질환을 해결하기 위해 확장 가능하고 증거에 기반한 솔루션을 찾고 있는 가운데, CoCM은 자원 사용을 최적화하면서 결과를 개선할 수 있는 구조적이면서도 유연한 프레임워크를 제공합니다. 임상적 수요, 정책적 추진력, 그리고 디지털화에 힘입어 민관 모두에서 도입이 확대되고 있습니다.
이러한 모멘텀이 지속되려면 이해관계자들이 보상 정책을 조정하고, 다학제적 역량을 구축하며, 측정 기반 치료를 대규모로 지원하는 디지털 도구에 투자할 수 있는지에 달려있습니다. 행동주의 의료가 전인적 치료의 중심축으로 자리 잡으면서, 다양한 지역, 환자 요구, 치료 제공 환경에서 개인화되고 공평하며 비용 효율적인 서비스를 제공하는 복잡성 증가에 대응하기 위해 협업 케어 모델이 계속 진화할 수 있는지에 대한 의문이 제기되고 있습니다.
부문
전개(웹 기반, 클라우드 기반, 온프레미스), 용도(집단 기반 케어, 환자 중심 팀 케어, 측정 기반 치료, 증거 기반 케어, 어카운터블 케어, 기타 용도), 최종사용자(병원 및 클리닉, 외래 케어 센터, 재활 센터, 학술연구기관, 기타 최종사용자)
조사 대상 기업 사례(총 합계 48개사)
AIMS Center, University of Washington
Allied Behavioral Health Integration
Altruix
American Psychiatric Association
CenterWell(Humana)
Cityblock Health
Concert Health
FOLX Health
Healthy Minds Policy Initiative
Innerworld
Magellan Healthcare
Manatt Health
Mindoula Health
Mirah
NeuroFlow
Pearl Health
Primary Care Collaborative
SAMHSA
The Banyan
Well Health Inc.
관세 영향 계수
Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 인위적인 매출원가 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.
Global Industry Analysts는 세계 주요 수석 이코노미스트(1,4,949명), 싱크탱크(62개 기관), 무역 및 산업 단체(171개 기관)의 전문가들의 의견을 면밀히 검토하여 생태계에 미치는 영향을 평가하고 새로운 시장 현실에 대응하고 있습니다. 모든 주요 국가의 전문가와 경제학자들이 관세와 그것이 자국에 미치는 영향에 대한 의견을 추적 조사하고 있습니다.
Global Industry Analysts는 이러한 혼란이 향후 2-3개월 내에 마무리되고 새로운 세계 질서가 보다 명확하게 확립될 것으로 예상하고 있으며, Global Industry Analysts는 이러한 상황을 실시간으로 추적하고 있습니다.
2025년 4월 : 협상 단계
이번 4월 보고서에서는 관세가 세계 시장 전체에 미치는 영향과 지역별 시장 조정에 대해 소개합니다. 당사의 예측은 과거 데이터와 진화하는 시장 영향요인을 기반으로 합니다.
2025년 7월 : 최종 관세 재설정
고객님들께는 각 국가별 최종 리셋이 발표된 후 7월에 무료 업데이트 버전을 제공해 드립니다. 최종 업데이트 버전에는 명확하게 정의된 관세 영향 분석이 포함되어 있습니다.
상호 및 양자 간 무역과 관세의 영향 분석:
미국 <> 중국 <> 멕시코 <> 캐나다 <> EU <> 일본 <> 인도 <> 기타 176개국
업계 최고의 이코노미스트 : Global Industry Analysts의 지식 기반은 국가, 싱크탱크, 무역 및 산업 단체, 대기업, 그리고 세계 계량 경제 상황의 전례 없는 패러다임 전환의 영향을 공유하는 분야별 전문가 등 가장 영향력 있는 수석 이코노미스트를 포함한 14,949명의 이코노미스트를 추적하고 있습니다. 16,491개 이상의 보고서 대부분에 마일스톤에 기반한 2단계 출시 일정이 적용되어 있습니다.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
KSM
영문 목차
영문목차
Global Collaborative Care Model Market to Reach US$4.9 Billion by 2030
The global market for Collaborative Care Model estimated at US$1.8 Billion in the year 2024, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 17.6% over the analysis period 2024-2030. Web-based Deployment, one of the segments analyzed in the report, is expected to record a 18.6% CAGR and reach US$3.0 Billion by the end of the analysis period. Growth in the Cloud-based Deployment segment is estimated at 16.2% CAGR over the analysis period.
The U.S. Market is Estimated at US$483.3 Million While China is Forecast to Grow at 16.5% CAGR
The Collaborative Care Model market in the U.S. is estimated at US$483.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$745.4 Million by the year 2030 trailing a CAGR of 16.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.3% and 15.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR.
Global Collaborative Care Model Market - Key Trends & Drivers Summarized
Why Is the Collaborative Care Model Emerging as a Critical Framework for Integrated Behavioral Health?
The Collaborative Care Model (CoCM) is gaining prominence as an evidence-based framework designed to integrate behavioral health services within primary care settings. Addressing long-standing fragmentation between mental and physical healthcare, this model promotes coordinated, patient-centered care through a team-based approach involving primary care providers, behavioral health clinicians, and psychiatric consultants. By embedding mental health services into general medical practice, CoCM enhances access, reduces stigma, and supports early intervention-particularly for conditions such as depression, anxiety, and substance use disorders.
Driven by the increasing recognition of mental health as a core determinant of overall health outcomes, this model is being actively pursued by health systems, insurers, and policymakers seeking to optimize chronic disease management and improve patient satisfaction. Evidence shows that collaborative care not only enhances clinical outcomes but also delivers cost efficiencies by reducing emergency visits, hospitalizations, and specialty referrals. As a scalable and adaptable framework, CoCM is increasingly viewed as a strategic lever to improve health equity and address unmet mental health needs across diverse populations.
How Are Digital Platforms and Clinical Protocols Enhancing the Efficacy of Collaborative Care?
Technology is playing a central role in enabling the scale and effectiveness of the Collaborative Care Model. Digital platforms are being used to facilitate care coordination, manage clinical registries, and monitor patient progress through standardized assessment tools such as PHQ-9 and GAD-7. These platforms allow behavioral care managers to track caseloads, prioritize outreach, and communicate seamlessly with primary care and psychiatric consultants-streamlining workflows and ensuring accountability across multidisciplinary teams.
Clinical protocols embedded within these platforms support evidence-based treatment pathways and ensure timely adjustments based on patient response. Measurement-based care-an essential component of CoCM-is increasingly being supported by patient-facing apps and telehealth tools that facilitate remote symptom tracking and virtual consultations. As demand grows for hybrid care delivery models, the integration of digital infrastructure is making it possible for collaborative care teams to serve geographically dispersed or resource-constrained populations without compromising care quality or continuity.
Which Health Systems and Patient Populations Are Driving Adoption of the Collaborative Care Model?
Large health systems, federally qualified health centers (FQHCs), accountable care organizations (ACOs), and integrated delivery networks (IDNs) are among the most active adopters of the Collaborative Care Model. These organizations benefit from the model’s alignment with value-based care goals and its ability to enhance performance metrics related to population health, care coordination, and patient satisfaction. CoCM is particularly impactful in primary care clinics where mental health resources are limited, enabling providers to offer structured psychiatric care without requiring direct psychiatrist availability onsite.
Patient populations with chronic medical comorbidities-such as diabetes, cardiovascular disease, and chronic pain-are prime beneficiaries of CoCM, given the frequent overlap with behavioral health conditions. The model is also well-suited for underserved communities where barriers to mental health access are high, including rural areas, Medicaid populations, and socioeconomically disadvantaged groups. By embedding behavioral services in trusted medical environments, the model improves uptake, reduces treatment delays, and enhances adherence among patients who might otherwise avoid or disengage from standalone mental health services.
How Are Policy Support, Reimbursement Structures, and Workforce Models Influencing Scalability?
Policy backing has been instrumental in driving the expansion of collaborative care, particularly in the U.S. where the Centers for Medicare & Medicaid Services (CMS) has approved specific billing codes to reimburse CoCM services. These codes incentivize care coordination and team-based interventions, providing a viable financial model for integrating behavioral health into primary care. Commercial payers are also beginning to align reimbursement frameworks with collaborative care principles, although variability in coverage and billing complexity remains a barrier in some regions.
Workforce availability and training are critical to effective implementation. The model relies on a dedicated behavioral care manager-often a licensed clinical social worker, psychologist, or nurse-supported by psychiatric consultation and primary care leadership. Expanding this workforce requires investment in cross-disciplinary training programs, clinical supervision structures, and technology adoption. Health systems that can cultivate collaborative culture and align financial incentives across care teams are more likely to sustain and scale the model successfully across diverse practice settings.
What Are the Factors Driving Growth in the Collaborative Care Model Market?
Growth in the Collaborative Care Model market is being propelled by rising awareness of the mental health crisis, the shift toward integrated and value-based healthcare, and the proven clinical and economic benefits of coordinated behavioral care. As health systems seek scalable, evidence-backed solutions to address psychiatric comorbidities within chronic disease populations, CoCM offers a structured yet flexible framework that improves outcomes while optimizing resource use. The convergence of clinical demand, policy momentum, and digital enablement is expanding adoption across public and private sectors.
The sustainability of this momentum will depend on the ability of stakeholders to align reimbursement policies, build interdisciplinary capacity, and invest in digital tools that support measurement-based care at scale. As behavioral health becomes a central pillar of whole-person care, the question is whether collaborative care models can continue to evolve to meet growing complexity-delivering personalized, equitable, and cost-efficient services across diverse geographies, patient needs, and care delivery environments.
SCOPE OF STUDY:
The report analyzes the Collaborative Care Model market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Deployment (Web-based, Cloud-based, On-Premise); Application (Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care, Other Applications); End-User (Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute, Other End-Users)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 48 Featured) -
AIMS Center, University of Washington
Allied Behavioral Health Integration
Altruix
American Psychiatric Association
CenterWell (Humana)
Cityblock Health
Concert Health
FOLX Health
Healthy Minds Policy Initiative
Innerworld
Magellan Healthcare
Manatt Health
Mindoula Health
Mirah
NeuroFlow
Pearl Health
Primary Care Collaborative
SAMHSA
The Banyan
Well Health Inc.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.
We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.
As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.
To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!
APRIL 2025: NEGOTIATION PHASE
Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.
JULY 2025 FINAL TARIFF RESET
Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.
Reciprocal and Bilateral Trade & Tariff Impact Analyses:
USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.
Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.
COMPLIMENTARY PREVIEW
Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Collaborative Care Model - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Integration of Behavioral Health Into Primary Care Settings Fuels Adoption of Collaborative Care Models
Reimbursement Models and Value-Based Care Metrics Support Growth of Team-Based Treatment Protocols
Digital Platforms Facilitate Communication Between Primary Providers, Psychiatrists, and Care Coordinators
Real-Time Mental Health Screening and Decision Support Tools Enhance Early Intervention Outcomes
Government Programs and Medicaid Expansion Encourage Widespread Use in Community Clinics
Collaborative Care Demonstrates Cost Savings and Improved Clinical Outcomes in Chronic Comorbidity Management
Employers and Payers Explore Collaborative Care for Workplace Mental Health Initiatives
Pediatric and Geriatric Populations Benefit From Multidisciplinary, Whole-Person Care Approaches
Expansion of Telepsychiatry and Virtual Health Platforms Strengthens Remote Collaborative Models
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Collaborative Care Model Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Collaborative Care Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 3: World 6-Year Perspective for Collaborative Care Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Web-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 5: World 6-Year Perspective for Web-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 6: World Recent Past, Current & Future Analysis for Cloud-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 7: World 6-Year Perspective for Cloud-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 9: World 6-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 11: World 6-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 12: World Recent Past, Current & Future Analysis for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 13: World 6-Year Perspective for Ambulatory Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Rehabilitation Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 15: World 6-Year Perspective for Rehabilitation Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Academic & Research Institute by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 17: World 6-Year Perspective for Academic & Research Institute by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 18: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 19: World 6-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Population-based Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 21: World 6-Year Perspective for Population-based Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Patient-centered Team Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 23: World 6-Year Perspective for Patient-centered Team Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 24: World Recent Past, Current & Future Analysis for Measurement-based Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 25: World 6-Year Perspective for Measurement-based Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Evidence-based Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 27: World 6-Year Perspective for Evidence-based Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Accountable Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 29: World 6-Year Perspective for Accountable Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 30: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 31: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Collaborative Care Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 32: USA Recent Past, Current & Future Analysis for Collaborative Care Model by Deployment - Web-based, Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 33: USA 6-Year Perspective for Collaborative Care Model by Deployment - Percentage Breakdown of Value Sales for Web-based, Cloud-based and On-Premise for the Years 2025 & 2030
TABLE 34: USA Recent Past, Current & Future Analysis for Collaborative Care Model by End-user - Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 35: USA 6-Year Perspective for Collaborative Care Model by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users for the Years 2025 & 2030
TABLE 36: USA Recent Past, Current & Future Analysis for Collaborative Care Model by Application - Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 37: USA 6-Year Perspective for Collaborative Care Model by Application - Percentage Breakdown of Value Sales for Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications for the Years 2025 & 2030
CANADA
TABLE 38: Canada Recent Past, Current & Future Analysis for Collaborative Care Model by Deployment - Web-based, Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 39: Canada 6-Year Perspective for Collaborative Care Model by Deployment - Percentage Breakdown of Value Sales for Web-based, Cloud-based and On-Premise for the Years 2025 & 2030
TABLE 40: Canada Recent Past, Current & Future Analysis for Collaborative Care Model by End-user - Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 41: Canada 6-Year Perspective for Collaborative Care Model by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users for the Years 2025 & 2030
TABLE 42: Canada Recent Past, Current & Future Analysis for Collaborative Care Model by Application - Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 43: Canada 6-Year Perspective for Collaborative Care Model by Application - Percentage Breakdown of Value Sales for Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications for the Years 2025 & 2030
JAPAN
Collaborative Care Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 44: Japan Recent Past, Current & Future Analysis for Collaborative Care Model by Deployment - Web-based, Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 45: Japan 6-Year Perspective for Collaborative Care Model by Deployment - Percentage Breakdown of Value Sales for Web-based, Cloud-based and On-Premise for the Years 2025 & 2030
TABLE 46: Japan Recent Past, Current & Future Analysis for Collaborative Care Model by End-user - Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 47: Japan 6-Year Perspective for Collaborative Care Model by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users for the Years 2025 & 2030
TABLE 48: Japan Recent Past, Current & Future Analysis for Collaborative Care Model by Application - Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 49: Japan 6-Year Perspective for Collaborative Care Model by Application - Percentage Breakdown of Value Sales for Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications for the Years 2025 & 2030
CHINA
Collaborative Care Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 50: China Recent Past, Current & Future Analysis for Collaborative Care Model by Deployment - Web-based, Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 51: China 6-Year Perspective for Collaborative Care Model by Deployment - Percentage Breakdown of Value Sales for Web-based, Cloud-based and On-Premise for the Years 2025 & 2030
TABLE 52: China Recent Past, Current & Future Analysis for Collaborative Care Model by End-user - Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 53: China 6-Year Perspective for Collaborative Care Model by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users for the Years 2025 & 2030
TABLE 54: China Recent Past, Current & Future Analysis for Collaborative Care Model by Application - Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 55: China 6-Year Perspective for Collaborative Care Model by Application - Percentage Breakdown of Value Sales for Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications for the Years 2025 & 2030
EUROPE
Collaborative Care Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 56: Europe Recent Past, Current & Future Analysis for Collaborative Care Model by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 57: Europe 6-Year Perspective for Collaborative Care Model by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
TABLE 58: Europe Recent Past, Current & Future Analysis for Collaborative Care Model by Deployment - Web-based, Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 59: Europe 6-Year Perspective for Collaborative Care Model by Deployment - Percentage Breakdown of Value Sales for Web-based, Cloud-based and On-Premise for the Years 2025 & 2030
TABLE 60: Europe Recent Past, Current & Future Analysis for Collaborative Care Model by End-user - Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 61: Europe 6-Year Perspective for Collaborative Care Model by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users for the Years 2025 & 2030
TABLE 62: Europe Recent Past, Current & Future Analysis for Collaborative Care Model by Application - Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 63: Europe 6-Year Perspective for Collaborative Care Model by Application - Percentage Breakdown of Value Sales for Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications for the Years 2025 & 2030
FRANCE
Collaborative Care Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 64: France Recent Past, Current & Future Analysis for Collaborative Care Model by Deployment - Web-based, Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 65: France 6-Year Perspective for Collaborative Care Model by Deployment - Percentage Breakdown of Value Sales for Web-based, Cloud-based and On-Premise for the Years 2025 & 2030
TABLE 66: France Recent Past, Current & Future Analysis for Collaborative Care Model by End-user - Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 67: France 6-Year Perspective for Collaborative Care Model by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users for the Years 2025 & 2030
TABLE 68: France Recent Past, Current & Future Analysis for Collaborative Care Model by Application - Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 69: France 6-Year Perspective for Collaborative Care Model by Application - Percentage Breakdown of Value Sales for Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications for the Years 2025 & 2030
GERMANY
Collaborative Care Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 70: Germany Recent Past, Current & Future Analysis for Collaborative Care Model by Deployment - Web-based, Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 71: Germany 6-Year Perspective for Collaborative Care Model by Deployment - Percentage Breakdown of Value Sales for Web-based, Cloud-based and On-Premise for the Years 2025 & 2030
TABLE 72: Germany Recent Past, Current & Future Analysis for Collaborative Care Model by End-user - Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 73: Germany 6-Year Perspective for Collaborative Care Model by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users for the Years 2025 & 2030
TABLE 74: Germany Recent Past, Current & Future Analysis for Collaborative Care Model by Application - Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 75: Germany 6-Year Perspective for Collaborative Care Model by Application - Percentage Breakdown of Value Sales for Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications for the Years 2025 & 2030
ITALY
TABLE 76: Italy Recent Past, Current & Future Analysis for Collaborative Care Model by Deployment - Web-based, Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 77: Italy 6-Year Perspective for Collaborative Care Model by Deployment - Percentage Breakdown of Value Sales for Web-based, Cloud-based and On-Premise for the Years 2025 & 2030
TABLE 78: Italy Recent Past, Current & Future Analysis for Collaborative Care Model by End-user - Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 79: Italy 6-Year Perspective for Collaborative Care Model by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users for the Years 2025 & 2030
TABLE 80: Italy Recent Past, Current & Future Analysis for Collaborative Care Model by Application - Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 81: Italy 6-Year Perspective for Collaborative Care Model by Application - Percentage Breakdown of Value Sales for Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications for the Years 2025 & 2030
UNITED KINGDOM
Collaborative Care Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 82: UK Recent Past, Current & Future Analysis for Collaborative Care Model by Deployment - Web-based, Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 83: UK 6-Year Perspective for Collaborative Care Model by Deployment - Percentage Breakdown of Value Sales for Web-based, Cloud-based and On-Premise for the Years 2025 & 2030
TABLE 84: UK Recent Past, Current & Future Analysis for Collaborative Care Model by End-user - Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 85: UK 6-Year Perspective for Collaborative Care Model by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users for the Years 2025 & 2030
TABLE 86: UK Recent Past, Current & Future Analysis for Collaborative Care Model by Application - Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 87: UK 6-Year Perspective for Collaborative Care Model by Application - Percentage Breakdown of Value Sales for Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications for the Years 2025 & 2030
REST OF EUROPE
TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Collaborative Care Model by Deployment - Web-based, Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 89: Rest of Europe 6-Year Perspective for Collaborative Care Model by Deployment - Percentage Breakdown of Value Sales for Web-based, Cloud-based and On-Premise for the Years 2025 & 2030
TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Collaborative Care Model by End-user - Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 91: Rest of Europe 6-Year Perspective for Collaborative Care Model by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users for the Years 2025 & 2030
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Collaborative Care Model by Application - Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 93: Rest of Europe 6-Year Perspective for Collaborative Care Model by Application - Percentage Breakdown of Value Sales for Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications for the Years 2025 & 2030
ASIA-PACIFIC
Collaborative Care Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Collaborative Care Model by Deployment - Web-based, Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 95: Asia-Pacific 6-Year Perspective for Collaborative Care Model by Deployment - Percentage Breakdown of Value Sales for Web-based, Cloud-based and On-Premise for the Years 2025 & 2030
TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Collaborative Care Model by End-user - Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 97: Asia-Pacific 6-Year Perspective for Collaborative Care Model by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users for the Years 2025 & 2030
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Collaborative Care Model by Application - Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 99: Asia-Pacific 6-Year Perspective for Collaborative Care Model by Application - Percentage Breakdown of Value Sales for Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications for the Years 2025 & 2030
REST OF WORLD
TABLE 100: Rest of World Recent Past, Current & Future Analysis for Collaborative Care Model by Deployment - Web-based, Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 101: Rest of World 6-Year Perspective for Collaborative Care Model by Deployment - Percentage Breakdown of Value Sales for Web-based, Cloud-based and On-Premise for the Years 2025 & 2030
TABLE 102: Rest of World Recent Past, Current & Future Analysis for Collaborative Care Model by End-user - Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 103: Rest of World 6-Year Perspective for Collaborative Care Model by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Care Centers, Rehabilitation Centers, Academic & Research Institute and Other End-Users for the Years 2025 & 2030
TABLE 104: Rest of World Recent Past, Current & Future Analysis for Collaborative Care Model by Application - Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 105: Rest of World 6-Year Perspective for Collaborative Care Model by Application - Percentage Breakdown of Value Sales for Population-based Care, Patient-centered Team Care, Measurement-based Treatment, Evidence-based Care, Accountable Care and Other Applications for the Years 2025 & 2030